UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 220

Sortiert nach

The Evolving Mechanisms of Action of Glatiramer Acetate

Cold Spring Harbor perspectives in medicine, 2019-02, Vol.9 (2), p.a029249

2019

Link zum Volltext

Verfügbarkeit prüfen

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Nature Reviews: Immunology, 2006-05, Vol.6 (5), p.358-370

2006

Link zum Volltext

Verfügbarkeit prüfen

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α

Nature communications, 2018-02, Vol.9 (1), p.559-15, Article 559

2018

Link zum Volltext

Verfügbarkeit prüfen

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

Proceedings of the National Academy of Sciences - PNAS, 2016-04, Vol.113 (17), p.4777-4782

2016

Link zum Volltext

Verfügbarkeit prüfen

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

Nature immunology, 2015-06, Vol.16 (6), p.618

2015

Link zum Volltext

Verfügbarkeit prüfen

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2020-09, Vol.117 (37), p.22932-22943

2020

Link zum Volltext

Verfügbarkeit prüfen

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

The Journal of experimental medicine, 2013-12, Vol.210 (13), p.2921-2937

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

Nature communications, 2015-09, Vol.6 (1), p.8164-8164, Article 8164

2015

Link zum Volltext

Verfügbarkeit prüfen

A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis

Nature communications, 2021-01, Vol.12 (1), p.635-635, Article 635

2021

Link zum Volltext

Verfügbarkeit prüfen

Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis

Trends in Immunology, 2005-11, Vol.26 (11), p.565-571

2005

Link zum Volltext

Verfügbarkeit prüfen

Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis

Experimental neurology, 2014-12, Vol.262, p.66-71

2014

Link zum Volltext

Verfügbarkeit prüfen

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

PloS one, 2012-03, Vol.7 (3), p.e33797-e33797

2012

Link zum Volltext

Verfügbarkeit prüfen

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

BMC neurology, 2016-09, Vol.16 (1), p.182-182, Article 182

2016

Link zum Volltext

Verfügbarkeit prüfen

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Nature (London), 2002-11, Vol.420 (6911), p.78-84

2002

Link zum Volltext

Verfügbarkeit prüfen

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (11), p.4355-4359

2009

Link zum Volltext

Verfügbarkeit prüfen

Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis

Journal of neuroinflammation, 2019-11, Vol.16 (1), p.203-203, Article 203

2019

Link zum Volltext

Verfügbarkeit prüfen

Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis

Neuron, 2003-06, Vol.38 (5), p.685-688

2003

Link zum Volltext

Verfügbarkeit prüfen

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

Neurobiology of disease, 2012-08, Vol.47 (2), p.280-293

2012

Link zum Volltext

Verfügbarkeit prüfen

Microglia complement astrocytes in neuromyelitis optica

The Journal of clinical investigation, 2020-08, Vol.130 (8), p.3961-3964

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 220

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library Journals Frontfile Complete

SpracheFranzösisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(196)

Publikationsform

Artikel
(219)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(166)
Life Sciences & Biomedicine
(143)
Humans
(102)
Neurosciences & Neurology
(94)
Clinical Neurology
(82)
Animals
(81)
Neurosciences
(78)
Multiple Sclerosis
(71)
Mice
(62)
Immunology
(42)
Female
(40)
Multiple Sclerosis - Immunology
(35)
Encephalomyelitis, Autoimmune, Experimental - Immunology
(34)
Neurology
(34)
Multiple Sclerosis - Drug Therapy
(31)
Mice, Inbred C57bl
(24)
Multidisciplinary Sciences
(23)
Science & Technology - Other Topics
(23)
T-Lymphocytes - Immunology
(22)
Biological And Medical Sciences
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The Evolving Mechanisms of Action of Glatiramer Acetate

Statin therapy and autoimmune disease: from protein prenylation to immunomodulation

Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α

Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2

Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10

The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis

Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration

Blood coagulation protein fibrinogen promotes autoimmunity and demyelination via chemokine release and antigen presentation

A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis

Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis

Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10

Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity

Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controls

Multiple sclerosis therapies differentially affect SARS-CoV-2 vaccine-induced antibody and T cell immunity and function

The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1β in human monocytes and multiple sclerosis

Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis

Diverse Targets for Intervention during Inflammatory and Neurodegenerative Phases of Multiple Sclerosis

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis

Microglia complement astrocytes in neuromyelitis optica

Aktive Filter

Suchergebnisse filtern